United World Antiviral Research Network; global effort to study emerging viruses and HIV-related coronaviruses
Official title: United World Antiviral Research Network (UWARN)
Funded at University of Washington · NIH-11617086 · Data updated 2026-11-12
A global research effort based in Seattle is studying emerging viruses, including SARS-CoV-2 variants and arboviruses, with partners in LMICs to improve detection, understanding, and responses in diverse populations.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 22, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $21,600 |
| NIH project number | 3U01AI151698-06S5 |
| Project ID | NIH-11617086 on NIH RePORTER |
Who could benefit from this research
✓Could help
Public health professionals and researchers in LMICs and high-burden regions who participate in surveillance and collaborative studies.
✕Less likely to help
Direct patient benefit is unlikely for individuals not involved in surveillance or clinical studies, though communities may benefit from improved outbreak preparedness.
What this research studies
UWARN is a NIH CREID Center led from the University of Washington with partners in Brazil, Senegal, and Taiwan, and it plans to expand to additional collaborators in Thailand. The project uses a One Health approach to study viruses in humans, animals, and the environment, focusing on detection, evolution, and transmission of arboviruses and coronaviruses. Researchers will track how viruses evolve in people living with HIV and in different regions, and will explore environmental factors driving spread. The center has produced numerous publications and trained researchers, and will continue to build capacity in LMIC settings to respond to outbreaks. The overall goal is to improve global surveillance, understanding, and preparedness for emerging infectious diseases.
Why it matters
Potential benefit: If successful, this work could improve global detection of dangerous viruses and inform better prevention and response strategies for outbreaks in at-risk communities.
How similar studies have gone: Many collaborations under CREID have yielded publications and capacity-building; the approach is established with potential for impact, expansion, and new discoveries.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Rabinowitz, Peter Macgarr — University of Washington
- Study coordinator: Rabinowitz, Peter Macgarr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.